Effectiveness of Intensive Training in Upper Limb Rehabilitation After Stroke.

NCT ID: NCT06571292

Last Updated: 2024-12-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

16 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-07-05

Study Completion Date

2024-10-04

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study is to analyse the effect of intensive training on upper limb function in stroke patients.

16 stroke patients were randomly divided into two groups: the intensive group and the control group.

The control group will be trained with robotic exoskeleton for upper limbs and task specific training, 3 sessions per week for 4 weeks, for 1 hour per day.

The intensive group will do robotic exoskeleton for upper limbs and task specific training, 5 sessions a week for 4 weeks, for 2 hours a day.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Abtract

Aim: The aim of the study is to analyze the effect of intensive training on upper limb function in stroke patients.

Methods: The control group will be trained with robotic exoskeleton for upper limbs and task specific training, 3 sessions per week for 4 weeks, for 1 hour per day.

The intensive group will do robotic exoskeleton for upper limbs and task specific training, 5 sessions a week for 4 weeks, for 2 hours a day. The primary outcome measure include is the Fugl Meyer Assessment (FMA).Secondary measures include the Box and Blocks Test (BBT), dynamometer, Motor Activity Log (MAL), Stroke Impact Scale (SIS), Functional Independence Measure (FIM) and Canadian Occupational Performance Measure (COPM).

Assessments occur at baseline, after 4 weeks of intervention, and at 1 month after intervention commencement. Analysis will be intention to treat using a generalised linear mixed model to report estimated mean differences in scores between the two groups at each timepoint with 95% confidence Interval and value p.

Hypothesis: If an intensive training programme is effective in improving upper limb motor function, its implementation for clinical practice could be beneficial for improving upper limb motor function and quality of life in people who have suffered a stroke.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stroke

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Stroke intensive training upper limb occupational therapy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors
The principal investigator will not carry out any intervention or outcome evaluation.

Both the principal investigator and the investigators of the interventions will be blinded to the data of the measurements that have been taken, and must leave the room during the assessment period.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control group

The control group will be trained with robotic exoskeleton for upper limbs and task specific training, 3 sessions per week for 4 weeks, for 1 hour per day.

Group Type ACTIVE_COMPARATOR

Intensive training with robotic exoskeleton for upper limbs

Intervention Type DEVICE

Both groups will be trained with robotic exoskeleton for upper limbs and task specific training.

Task specific training

Intervention Type DEVICE

Both groups will be trained with robotic exoskeleton for upper limbs and task specific training.

Intensive group

The intensive group will be trained with robotic exoskeleton for upper limbs and task specific training, 5 sessions per week for 4 weeks, for 2 hours per day.

Group Type EXPERIMENTAL

Intensive training with robotic exoskeleton for upper limbs

Intervention Type DEVICE

Both groups will be trained with robotic exoskeleton for upper limbs and task specific training.

Task specific training

Intervention Type DEVICE

Both groups will be trained with robotic exoskeleton for upper limbs and task specific training.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Intensive training with robotic exoskeleton for upper limbs

Both groups will be trained with robotic exoskeleton for upper limbs and task specific training.

Intervention Type DEVICE

Task specific training

Both groups will be trained with robotic exoskeleton for upper limbs and task specific training.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* People diagnosed with stroke (ischaemic or haemorrhagic).
* Patients in a subacute or chronic state.
* Patients must be over 18 years of age and under 80 years of age.
* Patients with impaired functionality of the upper limb.

* Mini-Mental State Examination (MMSE), the minimum score to be achieved will be 22 points.
* Severe difficulties in understanding language (aphasia).
* Behavioural or behavioural disturbance.
* Treatment with botulinum toxin 3 months prior to the intervention.
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Universidad de Zaragoza

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Enrique Villa Berges

PhD Principal investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Zaragoza

Zaragoza, Zaragoza, Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Spain

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

University Zaragoza

Identifier Type: -

Identifier Source: org_study_id